CytoSorbents Corp.
CytoSorbents is dedicated to advancing blood purification technology through innovative solutions that address critical health challenges. Their proprietary bead technology effectively removes harmful substances from the blood, providing healthcare professionals with powerful tools to improve patient outcomes in various medical conditions. The company is also focused on expanding its product offerings to include solutions for organ perfusion and antithrombotic removal. CytoSorb therapy is recognized for its ability to stabilize macro-hemodynamics, improve tissue perfusion, protect vital organs, and reduce bleeding complications, leading to enhanced patient recovery and high survival rates. CytoSorb is particularly effective in critical care settings, addressing systemic hyperinflammation and improving outcomes in patients with conditions such as septic shock and acute respiratory distress syndrome (ARDS). Additionally, CytoSorbents emphasizes the importance of training and education for healthcare professionals, ensuring they are equipped with the knowledge and skills to effectively utilize their technologies.
Industries
Nr. of Employees
medium (51-250)
CytoSorbents Corp.
Monmouth Junction, New Jersey, United States, North America
Products
Disposable adsorption cartridge for extracorporeal blood and perfusate purification
Sterile, single-use whole-blood adsorption cartridge containing porous polymer sorbent media designed to remove cytokines, bilirubin, myoglobin and other hydrophobic or protein-bound small molecules from blood and perfusate.
Mobile standalone adsorption console
Mobile console engineered to run disposable adsorption cartridges independently of dialysis equipment; includes automated priming, touchscreen interface, circuit monitoring and pre-assembled line kits.
High-flow sorbent cartridge for ex vivo organ perfusion
Sterile, single-use sorbent cartridge designed for incorporation into ex vivo organ perfusion circuits to remove inflammatory mediators from perfusate and support organ preservation and reconditioning prior to transplantation.
Investigational intraoperative drug-removal system
Investigational intraoperative sorbent-based system under clinical evaluation to remove recently administered antithrombotic drugs during cardiothoracic surgery to reduce perioperative bleeding risk.
Veterinary-adapted adsorption solutions
Devices and clinical workflows adapted from human extracorporeal adsorption technology for emergency veterinary applications to remove harmful bloodborne substances in animals.
Preclinical plasma antibody-removal adsorber prototype
Development-stage adsorption filter prototype intended to selectively remove anti-A and anti-B antibodies from plasma to produce low-titer universal plasma for off-the-shelf transfusion use; preclinical testing completed.
Disposable adsorption cartridge for extracorporeal blood and perfusate purification
Sterile, single-use whole-blood adsorption cartridge containing porous polymer sorbent media designed to remove cytokines, bilirubin, myoglobin and other hydrophobic or protein-bound small molecules from blood and perfusate.
Mobile standalone adsorption console
Mobile console engineered to run disposable adsorption cartridges independently of dialysis equipment; includes automated priming, touchscreen interface, circuit monitoring and pre-assembled line kits.
High-flow sorbent cartridge for ex vivo organ perfusion
Sterile, single-use sorbent cartridge designed for incorporation into ex vivo organ perfusion circuits to remove inflammatory mediators from perfusate and support organ preservation and reconditioning prior to transplantation.
Investigational intraoperative drug-removal system
Investigational intraoperative sorbent-based system under clinical evaluation to remove recently administered antithrombotic drugs during cardiothoracic surgery to reduce perioperative bleeding risk.
Veterinary-adapted adsorption solutions
Devices and clinical workflows adapted from human extracorporeal adsorption technology for emergency veterinary applications to remove harmful bloodborne substances in animals.
Preclinical plasma antibody-removal adsorber prototype
Development-stage adsorption filter prototype intended to selectively remove anti-A and anti-B antibodies from plasma to produce low-titer universal plasma for off-the-shelf transfusion use; preclinical testing completed.
Services
Clinical training, education and events program
Multilingual training and educational materials combined with organization and participation in regional and international conferences, webinars and on-demand content to support clinician training, device implementation and dissemination of clinical evidence.
Literature repository and registry support
Access to a centralized literature database and operational support for participation in clinical studies and registries to capture real-world use and outcomes; includes curated peer-reviewed publications, case reports and conference materials.
On-demand clinical consultation and operational support
Remote and field clinical consultation for device setup, case management, troubleshooting and protocol adaptation in critical care, surgical and transplant settings.
Distributor and global supply support
Management of distributor networks and regional logistics to enable availability of sterile consumables, local regulatory support and market access across multiple countries.
Clinical guidance materials and decision-support tools
Provision of indication-specific flowcharts, brochures, recommended literature lists and online scoring tools to assist clinician decision-making on therapy initiation and management.
Reimbursement and coding support
Country-specific coding and reimbursement assistance including documentation of national procedure codes, supplementary payment mechanisms and advisory materials to support local billing and payor discussions.
Clinical training, education and events program
Multilingual training and educational materials combined with organization and participation in regional and international conferences, webinars and on-demand content to support clinician training, device implementation and dissemination of clinical evidence.
Literature repository and registry support
Access to a centralized literature database and operational support for participation in clinical studies and registries to capture real-world use and outcomes; includes curated peer-reviewed publications, case reports and conference materials.
On-demand clinical consultation and operational support
Remote and field clinical consultation for device setup, case management, troubleshooting and protocol adaptation in critical care, surgical and transplant settings.
Distributor and global supply support
Management of distributor networks and regional logistics to enable availability of sterile consumables, local regulatory support and market access across multiple countries.
Clinical guidance materials and decision-support tools
Provision of indication-specific flowcharts, brochures, recommended literature lists and online scoring tools to assist clinician decision-making on therapy initiation and management.
Reimbursement and coding support
Country-specific coding and reimbursement assistance including documentation of national procedure codes, supplementary payment mechanisms and advisory materials to support local billing and payor discussions.
Expertise Areas
- Extracorporeal blood purification and hemoadsorption
- Ex vivo organ perfusion and perfusate purification
- Critical care and perioperative adjunctive blood-purification workflows (sepsis, shock, hyperinflammation)
- Integration of sorbent therapies with ECMO, CPB and CRRT circuits
Key Technologies
- High-surface-area porous polymer adsorption media
- Concentration- and size-dependent hydrophobic and protein-bound adsorption (documented up to ~60 kDa)
- Disposable whole-blood and perfusate sorbent cartridges
- High-flow, low-resistance cartridge architectures for organ perfusion